Addictions Therapeutics Market, Global Outlook and Forecast 2022-2028

March 2022 | 68 pages | ID: AD62A9E1F7B5EN
Market Monitor Global

Abstracts

Addiction is a brain disorder characterized by compulsive engagement in rewarding stimuli despite adverse consequences.Despite the involvement of a number of psychosocial factors, a biological process – one which is induced by repeated exposure to an addictive stimulus – is the core pathology that drives the development and maintenance of an addiction.

This report contains market size and forecasts of Addictions Therapeutics in Global, including the following market information:

Global Addictions Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Addictions Therapeutics market was valued at 4883 million in 2021 and is projected to reach US$ 6471.5 million by 2028, at a CAGR of 4.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Alcohol Addiction Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Addictions Therapeutics include Alkermes Plc, Amneal Pharmaceuticals Inc., Indivior Plc, Johnson & Johnson Services Inc., Mylan NV, Novartis AG, Novo Nordisk AS, Opiant Pharmaceuticals Inc. and Pfizer Inc. and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Addictions Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Addictions Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Addictions Therapeutics Market Segment Percentages, by Type, 2021 (%)

• Alcohol Addiction Therapeutics
• Tobacco Addiction Therapeutics
• Drug Addiction Therapeutics

Global Addictions Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Addictions Therapeutics Market Segment Percentages, by Application, 2021 (%)

• Public
• Private
• Government

Global Addictions Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Addictions Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Addictions Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Addictions Therapeutics revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Alkermes Plc
• Amneal Pharmaceuticals Inc.
• Indivior Plc
• Johnson & Johnson Services Inc.
• Mylan NV
• Novartis AG
• Novo Nordisk AS
• Opiant Pharmaceuticals Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Addictions Therapeutics Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Addictions Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL ADDICTIONS THERAPEUTICS OVERALL MARKET SIZE

2.1 Global Addictions Therapeutics Market Size: 2021 VS 2028
2.2 Global Addictions Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Addictions Therapeutics Players in Global Market
3.2 Top Global Addictions Therapeutics Companies Ranked by Revenue
3.3 Global Addictions Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Addictions Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Addictions Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Addictions Therapeutics Players in Global Market
  3.6.1 List of Global Tier 1 Addictions Therapeutics Companies
  3.6.2 List of Global Tier 2 and Tier 3 Addictions Therapeutics Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Addictions Therapeutics Market Size Markets, 2021 & 2028
  4.1.2 Alcohol Addiction Therapeutics
  4.1.3 Tobacco Addiction Therapeutics
  4.1.4 Drug Addiction Therapeutics
4.2 By Type - Global Addictions Therapeutics Revenue & Forecasts
  4.2.1 By Type - Global Addictions Therapeutics Revenue, 2017-2022
  4.2.2 By Type - Global Addictions Therapeutics Revenue, 2023-2028
  4.2.3 By Type - Global Addictions Therapeutics Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Addictions Therapeutics Market Size, 2021 & 2028
  5.1.2 Public
  5.1.3 Private
  5.1.4 Government
5.2 By Application - Global Addictions Therapeutics Revenue & Forecasts
  5.2.1 By Application - Global Addictions Therapeutics Revenue, 2017-2022
  5.2.2 By Application - Global Addictions Therapeutics Revenue, 2023-2028
  5.2.3 By Application - Global Addictions Therapeutics Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Addictions Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Addictions Therapeutics Revenue & Forecasts
  6.2.1 By Region - Global Addictions Therapeutics Revenue, 2017-2022
  6.2.2 By Region - Global Addictions Therapeutics Revenue, 2023-2028
  6.2.3 By Region - Global Addictions Therapeutics Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Addictions Therapeutics Revenue, 2017-2028
  6.3.2 US Addictions Therapeutics Market Size, 2017-2028
  6.3.3 Canada Addictions Therapeutics Market Size, 2017-2028
  6.3.4 Mexico Addictions Therapeutics Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Addictions Therapeutics Revenue, 2017-2028
  6.4.2 Germany Addictions Therapeutics Market Size, 2017-2028
  6.4.3 France Addictions Therapeutics Market Size, 2017-2028
  6.4.4 U.K. Addictions Therapeutics Market Size, 2017-2028
  6.4.5 Italy Addictions Therapeutics Market Size, 2017-2028
  6.4.6 Russia Addictions Therapeutics Market Size, 2017-2028
  6.4.7 Nordic Countries Addictions Therapeutics Market Size, 2017-2028
  6.4.8 Benelux Addictions Therapeutics Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Addictions Therapeutics Revenue, 2017-2028
  6.5.2 China Addictions Therapeutics Market Size, 2017-2028
  6.5.3 Japan Addictions Therapeutics Market Size, 2017-2028
  6.5.4 South Korea Addictions Therapeutics Market Size, 2017-2028
  6.5.5 Southeast Asia Addictions Therapeutics Market Size, 2017-2028
  6.5.6 India Addictions Therapeutics Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Addictions Therapeutics Revenue, 2017-2028
  6.6.2 Brazil Addictions Therapeutics Market Size, 2017-2028
  6.6.3 Argentina Addictions Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Addictions Therapeutics Revenue, 2017-2028
  6.7.2 Turkey Addictions Therapeutics Market Size, 2017-2028
  6.7.3 Israel Addictions Therapeutics Market Size, 2017-2028
  6.7.4 Saudi Arabia Addictions Therapeutics Market Size, 2017-2028
  6.7.5 UAE Addictions Therapeutics Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Alkermes Plc
  7.1.1 Alkermes Plc Corporate Summary
  7.1.2 Alkermes Plc Business Overview
  7.1.3 Alkermes Plc Addictions Therapeutics Major Product Offerings
  7.1.4 Alkermes Plc Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.1.5 Alkermes Plc Key News
7.2 Amneal Pharmaceuticals Inc.
  7.2.1 Amneal Pharmaceuticals Inc. Corporate Summary
  7.2.2 Amneal Pharmaceuticals Inc. Business Overview
  7.2.3 Amneal Pharmaceuticals Inc. Addictions Therapeutics Major Product Offerings
  7.2.4 Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.2.5 Amneal Pharmaceuticals Inc. Key News
7.3 Indivior Plc
  7.3.1 Indivior Plc Corporate Summary
  7.3.2 Indivior Plc Business Overview
  7.3.3 Indivior Plc Addictions Therapeutics Major Product Offerings
  7.3.4 Indivior Plc Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.3.5 Indivior Plc Key News
7.4 Johnson & Johnson Services Inc.
  7.4.1 Johnson & Johnson Services Inc. Corporate Summary
  7.4.2 Johnson & Johnson Services Inc. Business Overview
  7.4.3 Johnson & Johnson Services Inc. Addictions Therapeutics Major Product Offerings
  7.4.4 Johnson & Johnson Services Inc. Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.4.5 Johnson & Johnson Services Inc. Key News
7.5 Mylan NV
  7.5.1 Mylan NV Corporate Summary
  7.5.2 Mylan NV Business Overview
  7.5.3 Mylan NV Addictions Therapeutics Major Product Offerings
  7.5.4 Mylan NV Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.5.5 Mylan NV Key News
7.6 Novartis AG
  7.6.1 Novartis AG Corporate Summary
  7.6.2 Novartis AG Business Overview
  7.6.3 Novartis AG Addictions Therapeutics Major Product Offerings
  7.6.4 Novartis AG Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.6.5 Novartis AG Key News
7.7 Novo Nordisk AS
  7.7.1 Novo Nordisk AS Corporate Summary
  7.7.2 Novo Nordisk AS Business Overview
  7.7.3 Novo Nordisk AS Addictions Therapeutics Major Product Offerings
  7.7.4 Novo Nordisk AS Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.7.5 Novo Nordisk AS Key News
7.8 Opiant Pharmaceuticals Inc.
  7.8.1 Opiant Pharmaceuticals Inc. Corporate Summary
  7.8.2 Opiant Pharmaceuticals Inc. Business Overview
  7.8.3 Opiant Pharmaceuticals Inc. Addictions Therapeutics Major Product Offerings
  7.8.4 Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.8.5 Opiant Pharmaceuticals Inc. Key News
7.9 Pfizer Inc.
  7.9.1 Pfizer Inc. Corporate Summary
  7.9.2 Pfizer Inc. Business Overview
  7.9.3 Pfizer Inc. Addictions Therapeutics Major Product Offerings
  7.9.4 Pfizer Inc. Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.9.5 Pfizer Inc. Key News
7.10 Teva Pharmaceutical Industries Ltd.
  7.10.1 Teva Pharmaceutical Industries Ltd. Corporate Summary
  7.10.2 Teva Pharmaceutical Industries Ltd. Business Overview
  7.10.3 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Major Product Offerings
  7.10.4 Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue in Global Market (2017-2022)
  7.10.5 Teva Pharmaceutical Industries Ltd. Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Addictions Therapeutics Market Opportunities & Trends in Global Market
Table 2. Addictions Therapeutics Market Drivers in Global Market
Table 3. Addictions Therapeutics Market Restraints in Global Market
Table 4. Key Players of Addictions Therapeutics in Global Market
Table 5. Top Addictions Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Addictions Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Addictions Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Addictions Therapeutics Product Type
Table 9. List of Global Tier 1 Addictions Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Addictions Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Addictions Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Addictions Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Addictions Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Addictions Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Addictions Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Addictions Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Addictions Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Addictions Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Addictions Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Addictions Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Addictions Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Addictions Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Addictions Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Addictions Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Addictions Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Addictions Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Addictions Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Addictions Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Addictions Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Alkermes Plc Corporate Summary
Table 31. Alkermes Plc Addictions Therapeutics Product Offerings
Table 32. Alkermes Plc Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. Amneal Pharmaceuticals Inc. Corporate Summary
Table 34. Amneal Pharmaceuticals Inc. Addictions Therapeutics Product Offerings
Table 35. Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Indivior Plc Corporate Summary
Table 37. Indivior Plc Addictions Therapeutics Product Offerings
Table 38. Indivior Plc Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Johnson & Johnson Services Inc. Corporate Summary
Table 40. Johnson & Johnson Services Inc. Addictions Therapeutics Product Offerings
Table 41. Johnson & Johnson Services Inc. Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Mylan NV Corporate Summary
Table 43. Mylan NV Addictions Therapeutics Product Offerings
Table 44. Mylan NV Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Novartis AG Corporate Summary
Table 46. Novartis AG Addictions Therapeutics Product Offerings
Table 47. Novartis AG Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Novo Nordisk AS Corporate Summary
Table 49. Novo Nordisk AS Addictions Therapeutics Product Offerings
Table 50. Novo Nordisk AS Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Opiant Pharmaceuticals Inc. Corporate Summary
Table 52. Opiant Pharmaceuticals Inc. Addictions Therapeutics Product Offerings
Table 53. Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Pfizer Inc. Corporate Summary
Table 55. Pfizer Inc. Addictions Therapeutics Product Offerings
Table 56. Pfizer Inc. Addictions Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. Teva Pharmaceutical Industries Ltd. Corporate Summary
Table 58. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Product Offerings
Table 59. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Addictions Therapeutics Segment by Type in 2021
Figure 2. Addictions Therapeutics Segment by Application in 2021
Figure 3. Global Addictions Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Addictions Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Addictions Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Addictions Therapeutics Revenue in 2021
Figure 8. By Type - Global Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Addictions Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Addictions Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Alkermes Plc Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Amneal Pharmaceuticals Inc. Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Indivior Plc Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Johnson & Johnson Services Inc. Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Mylan NV Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis AG Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novo Nordisk AS Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Opiant Pharmaceuticals Inc. Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Pfizer Inc. Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Teva Pharmaceutical Industries Ltd. Addictions Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)